Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Eric M. Mortensen, Marcos I. Restrepo, Antonio Anzueto, Jacqueline A. Pugh

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Purpose: Although numerous articles have demonstrated that recommended empiric antimicrobial regimens are associated with decreased mortality at 30 days, there is controversy over whether appropriate antibiotic selection has a beneficial impact on mortality within the first 48 to 96 hours after admission. Our aim was to determine whether the use of guideline-concordant antibiotic therapy is associated with decreased mortality within the first 48 hours after admission for patients with pneumonia. Methods: A retrospective cohort study was conducted at two tertiary teaching hospitals in San Antonio, Texas. A propensity score was used to balance the covariates associated with the use of guideline-concordant antimicrobial therapy. A multivariable logistic regression model was used to assess the association between mortality within 48 hours and the use of guideline-concordant antibiotic therapy, after adjusting for potential confounders including the propensity score. Results: Information was obtained on 787 patients with community-acquired pneumonia. The median age was 60 years, 79% were male, and 20% were initially admitted to the intensive care unit. At presentation 52% of subjects were low risk, 34% were moderate risk, and 14% were high risk. Within the first 48 hours, 20 patients died. After adjustment for potential confounders, the use of guideline-concordant antimicrobial therapy (odds ratio 0.37, 95% confidence interval, 0.14-0.95) was significantly associated with decreased mortality at 48 hours after admission. Conclusion: Using initial empiric guideline-concordant antimicrobial therapy is associated with decreased mortality at 48 hours. Further research needs to investigate methods to ensure that patients with community-acquired pneumonia are treated with appropriate antimicrobial therapies.

Original languageEnglish (US)
Pages (from-to)859-864
Number of pages6
JournalAmerican Journal of Medicine
Volume119
Issue number10
DOIs
StatePublished - Oct 2006

Fingerprint

Pneumonia
Anti-Bacterial Agents
Guidelines
Mortality
Propensity Score
Therapeutics
Logistic Models
Patient Admission
Tertiary Care Centers
Teaching Hospitals
Intensive Care Units
Cohort Studies
Retrospective Studies
Odds Ratio
Confidence Intervals
Research

Keywords

  • Antibacterial agents
  • Community-acquired infections
  • Pneumonia

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia. / Mortensen, Eric M.; Restrepo, Marcos I.; Anzueto, Antonio; Pugh, Jacqueline A.

In: American Journal of Medicine, Vol. 119, No. 10, 10.2006, p. 859-864.

Research output: Contribution to journalArticle

Mortensen, Eric M. ; Restrepo, Marcos I. ; Anzueto, Antonio ; Pugh, Jacqueline A. / Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia. In: American Journal of Medicine. 2006 ; Vol. 119, No. 10. pp. 859-864.
@article{b6a32071194b4b6c8c27a0687e2ce783,
title = "Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia",
abstract = "Purpose: Although numerous articles have demonstrated that recommended empiric antimicrobial regimens are associated with decreased mortality at 30 days, there is controversy over whether appropriate antibiotic selection has a beneficial impact on mortality within the first 48 to 96 hours after admission. Our aim was to determine whether the use of guideline-concordant antibiotic therapy is associated with decreased mortality within the first 48 hours after admission for patients with pneumonia. Methods: A retrospective cohort study was conducted at two tertiary teaching hospitals in San Antonio, Texas. A propensity score was used to balance the covariates associated with the use of guideline-concordant antimicrobial therapy. A multivariable logistic regression model was used to assess the association between mortality within 48 hours and the use of guideline-concordant antibiotic therapy, after adjusting for potential confounders including the propensity score. Results: Information was obtained on 787 patients with community-acquired pneumonia. The median age was 60 years, 79{\%} were male, and 20{\%} were initially admitted to the intensive care unit. At presentation 52{\%} of subjects were low risk, 34{\%} were moderate risk, and 14{\%} were high risk. Within the first 48 hours, 20 patients died. After adjustment for potential confounders, the use of guideline-concordant antimicrobial therapy (odds ratio 0.37, 95{\%} confidence interval, 0.14-0.95) was significantly associated with decreased mortality at 48 hours after admission. Conclusion: Using initial empiric guideline-concordant antimicrobial therapy is associated with decreased mortality at 48 hours. Further research needs to investigate methods to ensure that patients with community-acquired pneumonia are treated with appropriate antimicrobial therapies.",
keywords = "Antibacterial agents, Community-acquired infections, Pneumonia",
author = "Mortensen, {Eric M.} and Restrepo, {Marcos I.} and Antonio Anzueto and Pugh, {Jacqueline A.}",
year = "2006",
month = "10",
doi = "10.1016/j.amjmed.2006.04.017",
language = "English (US)",
volume = "119",
pages = "859--864",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

AU - Mortensen, Eric M.

AU - Restrepo, Marcos I.

AU - Anzueto, Antonio

AU - Pugh, Jacqueline A.

PY - 2006/10

Y1 - 2006/10

N2 - Purpose: Although numerous articles have demonstrated that recommended empiric antimicrobial regimens are associated with decreased mortality at 30 days, there is controversy over whether appropriate antibiotic selection has a beneficial impact on mortality within the first 48 to 96 hours after admission. Our aim was to determine whether the use of guideline-concordant antibiotic therapy is associated with decreased mortality within the first 48 hours after admission for patients with pneumonia. Methods: A retrospective cohort study was conducted at two tertiary teaching hospitals in San Antonio, Texas. A propensity score was used to balance the covariates associated with the use of guideline-concordant antimicrobial therapy. A multivariable logistic regression model was used to assess the association between mortality within 48 hours and the use of guideline-concordant antibiotic therapy, after adjusting for potential confounders including the propensity score. Results: Information was obtained on 787 patients with community-acquired pneumonia. The median age was 60 years, 79% were male, and 20% were initially admitted to the intensive care unit. At presentation 52% of subjects were low risk, 34% were moderate risk, and 14% were high risk. Within the first 48 hours, 20 patients died. After adjustment for potential confounders, the use of guideline-concordant antimicrobial therapy (odds ratio 0.37, 95% confidence interval, 0.14-0.95) was significantly associated with decreased mortality at 48 hours after admission. Conclusion: Using initial empiric guideline-concordant antimicrobial therapy is associated with decreased mortality at 48 hours. Further research needs to investigate methods to ensure that patients with community-acquired pneumonia are treated with appropriate antimicrobial therapies.

AB - Purpose: Although numerous articles have demonstrated that recommended empiric antimicrobial regimens are associated with decreased mortality at 30 days, there is controversy over whether appropriate antibiotic selection has a beneficial impact on mortality within the first 48 to 96 hours after admission. Our aim was to determine whether the use of guideline-concordant antibiotic therapy is associated with decreased mortality within the first 48 hours after admission for patients with pneumonia. Methods: A retrospective cohort study was conducted at two tertiary teaching hospitals in San Antonio, Texas. A propensity score was used to balance the covariates associated with the use of guideline-concordant antimicrobial therapy. A multivariable logistic regression model was used to assess the association between mortality within 48 hours and the use of guideline-concordant antibiotic therapy, after adjusting for potential confounders including the propensity score. Results: Information was obtained on 787 patients with community-acquired pneumonia. The median age was 60 years, 79% were male, and 20% were initially admitted to the intensive care unit. At presentation 52% of subjects were low risk, 34% were moderate risk, and 14% were high risk. Within the first 48 hours, 20 patients died. After adjustment for potential confounders, the use of guideline-concordant antimicrobial therapy (odds ratio 0.37, 95% confidence interval, 0.14-0.95) was significantly associated with decreased mortality at 48 hours after admission. Conclusion: Using initial empiric guideline-concordant antimicrobial therapy is associated with decreased mortality at 48 hours. Further research needs to investigate methods to ensure that patients with community-acquired pneumonia are treated with appropriate antimicrobial therapies.

KW - Antibacterial agents

KW - Community-acquired infections

KW - Pneumonia

UR - http://www.scopus.com/inward/record.url?scp=33748803938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748803938&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2006.04.017

DO - 10.1016/j.amjmed.2006.04.017

M3 - Article

C2 - 17000217

AN - SCOPUS:33748803938

VL - 119

SP - 859

EP - 864

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 10

ER -